Ranbaxy
This article was originally published in The Tan Sheet
Executive Summary
Firm receives tentative approval March 10 for ranitidine 75 mg tablets, equivalent to Glaxo Wellcome's Zantac 75. Glaxo received an additional six months of exclusivity for Zantac 75 until June 19 ("The Tan Sheet" Feb. 1, In Brief). More than a half-dozen firms now have tentative ANDA approvals for OTC ranitidine